Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6836-6840

  Hosch, Stefan ^a   Kraus, Jɒrgen ^b   Scheunemann, Peter ^a   Izbicki, Jakob Robert ^a   Schneider, Claus ^a   Schumacher, Udo ^a   Witter, Klaus ^b   Speicher, Michael R ^b   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR ANTIGEN;

ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOGENETICS; ESOPHAGUS CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICE, SCID; MICROSATELLITE REPEATS; MULTIVARIATE ANALYSIS; NEOPLASM TRANSPLANTATION; PROGNOSIS; SEQUENCE ANALYSIS, DNA; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034671758     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Detection and clinical importance of micrometastatic disease
2. Cryptic tumor cells in lymph nodes of patients with esophageal cancer
3. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood
4. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
5. Establishment of micrometastatic carcinoma cell lines: A novel source of tumor cell vaccines
6. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer
7. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer
8. A note on quantifying follow-up in studies of failure time
9. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma
10. A simple salting out procedure for extracting DNA from human nucleated cells
11. Non-radioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigeninlabelled oligonucleotides and chemiluminescence detection
12. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
13. Karyotyping human chromosomes by combinatorial multi-fluor FISH
14. An optimized, fully automated system for fast and accurate identification of chromosomal rearrangements by multiplex-FISH (MFISH)
15. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes
16. Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones
17. Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2
18. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss
19. Gains of 8q23-qter and 20q and loss of 11q22-qter in esophageal squamous cell carcinoma associated with lymph node metastasis
20. Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia
21. Y chromosome loss in esophageal carcinoma: An in situ hybridization study
22. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma
23. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer
24. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer
25. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
26. Antibodies as cytotoxic therapy